UC San Diego Joins National Trial to Explore New Vaccines for COVID-19 Variants

UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

Click to view original post

ADVERTISEMENT — Advertise With Biotech Networks